3.8 Article

Proteomics of immune cells from liver tumors reveals immunotherapy targets

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways

Lukas Kraehenbuehl et al.

Summary: The discovery and clinical implementation of immune-checkpoint inhibitors like CTLA4, PD-1, and PD-L1 have significantly improved outcomes for patients with advanced-stage cancers. However, a majority of patients do not respond to these agents, emphasizing the need for further research into alternative immunomodulatory pathways and targeting tumor metabolism to enhance treatment efficacy.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Review Oncology

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, specifically hepatocellular carcinoma (HCC), is the second leading cause of cancer-related death globally. Traditional treatments involve specific drugs, but the emergence of immune checkpoint inhibitors has revolutionized the management of HCC.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Review Biotechnology & Applied Microbiology

PROTAC targeted protein degraders: the past is prologue

Miklos Bekes et al.

Summary: Targeted protein degradation (TPD) is a new therapeutic modality that can tackle disease-causing proteins which are difficult to target with conventional small molecules. PROTAC molecules, utilizing the ubiquitin-proteasome system to degrade target proteins, has achieved clinical proof-of-concept and attracted significant industry activity. Future directions include identifying target classes suitable for TPD, expanding the use of ubiquitin ligases for precision medicine, and extending the modality beyond oncology.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Biochemistry & Molecular Biology

The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences

Yasset Perez-Riverol et al.

Summary: PRIDE is the largest data repository of mass spectrometry-based proteomics data in the world, with around 500 datasets submitted per month. In addition to continuous improvements in data pipelines and infrastructure, PRIDE has developed the Spectra Archive and MAGE-TAB file format to enhance sample metadata annotation and access to mass spectra.

NUCLEIC ACIDS RESEARCH (2022)

Article Oncology

Next-Generation CAR T-cell Therapies

Regina M. Young et al.

Summary: CD19 and BCMA-directed CAR T cells have shown remarkable efficacy in treating certain hematologic malignancies, but there are still unmet treatment needs. Next-generation CAR T cells will incorporate gene engineering and synthetic biology to improve functionality and persistence, and reduce treatment-related toxicities. Combining autologous CAR T cells with allogeneic cell treatment strategies targeting the tumor microenvironment will expand the impact of CAR T-cell therapies.

CANCER DISCOVERY (2022)

Review Immunology

Immunological insights in the treatment of chronic B

Matteo Iannacone et al.

Summary: HBV can cause acute or chronic liver diseases, with chronic hepatitis often leading to cirrhosis and liver cancer. Immunological events play a crucial role in the outcome of HBV infection, as the virus itself is not highly pathogenic. Current therapies rely on antiviral drugs but cannot completely eradicate the virus from the liver. A cure for chronic hepatitis B may require combining antiviral drugs with immune-stimulating approaches.

CURRENT OPINION IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Absolute protein quantitation of the mouse macrophage Toll-like receptor and chemotaxis pathways

Nathan P. Manes et al.

Summary: This study reports the development and application of targeted mass spectrometry assays to measure the absolute abundance of proteins in the TLR4 and chemotaxis pathways of mouse macrophages. The generated datasets can be used for pathway modeling and simulation, as well as other studies related to TLR and chemotaxis pathways.

SCIENTIFIC DATA (2022)

Review Immunology

CD8+ T cell differentiation and dysfunction in cancer

Mary Philip et al.

Summary: The article discusses the dysfunctional states of CD8(+) T cells in tumors and their impact on response and resistance to immunotherapy. The authors emphasize the heterogeneity of T cell states in tumors and the challenge of predicting which patients will respond to immunotherapeutic interventions.

NATURE REVIEWS IMMUNOLOGY (2022)

Review Multidisciplinary Sciences

Macrophage targeting in cancer

Martha Lopez-Yrigoyen et al.

Summary: Tumorigenesis is influenced by interactions between cancer cells and the tumor microenvironment. Tumor-associated macrophages play a crucial role in tumor development, with the potential to both promote antitumor responses and exhibit immunosuppressive protumor phenotypes. Targeting TAMs has become a strategy in cancer therapy, with a focus on reprogramming TAMs to support antitumor immune responses.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2021)

Article Biochemistry & Molecular Biology

An NK-like CAR T cell transition in CAR T cell dysfunction

Charly R. Good et al.

Summary: CAR T cell therapy has achieved success in hematological malignancies but faces challenges in solid tumors due to CAR T cell exhaustion. Dysfunction of CAR T cells in solid tumors is associated with CD8+ T-to-NK-like T cell transition, and genetic downregulation of ID3 and SOX4 expression can improve the efficacy of CAR T cell therapy.
Review Biochemistry & Molecular Biology

Counteracting CAR T cell dysfunction

Mansour Poorebrahim et al.

Summary: Despite the high rates of complete remission achieved through CAR T cell therapy, the efficacy of this approach is limited by dysfunctional CAR T cells, which can be improved through modifications to enhance antitumor functions and lifespan. Research is ongoing on blocking exhaustion and senescence in CAR T cells to boost potency in adoptive cell transfer therapies.

ONCOGENE (2021)

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Meeting Abstract Oncology

LANDSCAPE OF HELPER AND REGULATORY CD4+T CELLS IN MELANOMA

Giacomo Oliveira et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Editorial Material Biochemistry & Molecular Biology

SnapShot: Clinical proteomics

Yi Zhu et al.

Review Oncology

The immunological and metabolic landscape in primary and metastatic liver cancer

Xin Li et al.

Summary: This review discusses the unique immunological and metabolic features of the liver during cancer development, and how these factors can impact the development of primary liver cancer and liver metastases. The liver is often influenced by chronic inflammation and metabolic alterations, which may affect cancer metastasis.

NATURE REVIEWS CANCER (2021)

Article Immunology

Dynamics in protein translation sustaining T cell preparedness

Tobias Wolf et al.

NATURE IMMUNOLOGY (2020)

Article Immunology

CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer

Laura M. McLane et al.

Annual Review of Immunology (2019)

Article Biochemistry & Molecular Biology

A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer

Johanna Wagner et al.

Article Multidisciplinary Sciences

TOX is a critical regulator of tumour-specific T cell differentiation

Andrew C. Scott et al.

NATURE (2019)

Article Multidisciplinary Sciences

TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion

Omar Khan et al.

NATURE (2019)

Article Multidisciplinary Sciences

Comparative analysis of mRNA and protein degradation in prostate tissues indicates high stability of proteins

Wenguang Shao et al.

NATURE COMMUNICATIONS (2019)

Review Immunology

Sphingosine-1-Phosphate and Macrophage Biology-How the Sphinx Tames the Big Eater

Andreas Weigert et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Cell Biology

CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule

Chloe Sauzay et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

Article Pathology

Diversity, Mechanisms, and Significance of Macrophage Plasticity

Massimo Locati et al.

Annual Review of Pathology-Mechanisms of Disease (2019)

Article Biochemistry & Molecular Biology

Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma

Qiming Zhang et al.

Review Oncology

Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism

Jingjing Zhu et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)

Article Oncology

T Cell Dysfunction in Cancer

Daniela S. Thommen et al.

CANCER CELL (2018)

Article Immunology

Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells

Mara Kornete et al.

JOURNAL OF IMMUNOLOGY (2018)

Article Biochemistry & Molecular Biology

Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing

Xinyi Guo et al.

NATURE MEDICINE (2018)

Article Multidisciplinary Sciences

Lineage tracking reveals dynamic relationships of T cells in colorectal cancer

Lei Zhang et al.

NATURE (2018)

Article Oncology

CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8(+) T Cells

Fernando P. Canale et al.

CANCER RESEARCH (2018)

Article Multidisciplinary Sciences

Chromatin states define tumour-specific T cell dysfunction and reprogramming

Mary Philip et al.

NATURE (2017)

Article Gastroenterology & Hepatology

Identification of the Consistently Altered Metabolic Targets in Human Hepatocellular Carcinoma

Zeribe Chike Nwosu et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)

Article Biochemistry & Molecular Biology

Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing

Chunhong Zheng et al.

Article Biochemistry & Molecular Biology

Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses

Yonit Lavin et al.

Review Biochemistry & Molecular Biology

On the Dependency of Cellular Protein Levels on mRNA Abundance

Yansheng Liu et al.

Article Biochemistry & Molecular Biology

L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity

Roger Geiger et al.

Review Multidisciplinary Sciences

Mass-spectrometric exploration of proteome structure and function

Ruedi Aebersold et al.

NATURE (2016)

Article Medicine, Research & Experimental

PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors

Alena Gros et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Biochemistry & Molecular Biology

Easy quantitative assessment of genome editing by sequence trace decomposition

Eva K. Brinkman et al.

NUCLEIC ACIDS RESEARCH (2014)

Review Immunology

Living in the liver: hepatic infections

Ulrike Protzer et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Article Pathology

XB130, a Novel Adaptor Protein, Promotes Thyroid Tumor Growth

Atsushi Shiozaki et al.

AMERICAN JOURNAL OF PATHOLOGY (2011)

Article Biochemistry & Molecular Biology

Sphingosine-1-phosphate Lyase Deficiency Produces a Pro-inflammatory Response While Impairing Neutrophil Trafficking

Maria L. Allende et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemical Research Methods

Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment

Juergen Cox et al.

JOURNAL OF PROTEOME RESEARCH (2011)

Review Multidisciplinary Sciences

Scaffold Proteins: Hubs for Controlling the Flow of Cellular Information

Matthew C. Good et al.

SCIENCE (2011)

Review Immunology

The outs and the ins of sphingosine-1-phosphate in immunity

Sarah Spiegel et al.

NATURE REVIEWS IMMUNOLOGY (2011)

Article Biochemistry & Molecular Biology

XB130, a novel adaptor protein for signal transduction

Jing Xu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)